Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort
Lingying Wu, Jianqing Zhu, Rutie Yin, Xiaohua Wu, Ge Lou, Jing Wang, Yunong Gao, Beihua Kong, Xin Lu, Qi Zhou, Yueling Wang, Youguo Chen, Weiguo Lü, Wei Li, Ying Cheng, Jihong Liu, Xin Ma, Jing Zhang
Topics & Concepts
MedicineOlaparibOvarian cancerCohortOncologyChinaInternal medicineBRCA mutationGynecologyMutationCancerGeneticsGenePoly ADP ribose polymeraseBiologyPolitical sciencePolymeraseLawPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer